Increasing Capacity without Additional Capital Investment

By Marketing 2 years ago

Increasing Capacity without Additional Capital Investment

As a leading global pharmaceutical and biologic company, AstraZeneca needed a system that could simplify and enhance their complex processes as well as work with their current Lean Operation initiatives. AstraZeneca improved flexibility, responsiveness and quality by aligning TrakSYS™ to DMAIC (Define, Measure, Analyze, Improve, Control) principles. With OEE improvements of 10-40% reported across multiple lines, AstraZeneca increased capacity without additional capital investment and was able to produce an additional 1 million bottles per year without additional capital investment.

AstraZeneca’s Lean operations, paired with TrakSYS™, had goals to:

    1. Identify root causes of equipment downtime and become proactive
    2. Bottom line improvements of 10% in the first year
    3. Automate OEE data collection in formulation and packaging areas to improve visibility and Business Intelligence (BI)

Download the Case Study
to Learn More

Categories:
  Case StudiesLean ManufacturingOperations ManagementPerformance ManagementQuality & Compliance